4‐hydroxy tempo improves mitochondrial and neurobehavioral deficits in experimental model of Huntington's disease

E-ISSN： 1098-2396|69|3|128-138

ISSN： 0887-4476

Source： SYNAPSE (ELECTRONIC), Vol.69, Iss.3, 2015-03, pp. : 128-138

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tripchlorolide improves cognitive deficits by reducing amyloid β and upregulating synapse‐related proteins in a transgenic model of Alzheimer's Disease

JOURNAL OF NEUROCHEMISTRY (ELECTRONIC), Vol. 133, Iss. 1, 2015-04 ,pp. : 38-52

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effects of a Sativex-Like Combination of Phytocannabinoids on Disease Progression in R6/2 Mice, an Experimental Model of Huntington’s Disease

By Valdeolivas Sara Sagredo Onintza Delgado Mercedes Pozo Miguel A. Fernández-Ruiz Javier

International Journal of Molecular Sciences, Vol. 18, Iss. 4, 2017-03 ,pp. : 684-684

MDPI

Access to resources Recommend Favorite

Resorcylidene Aminoguanidine (RAG) Improves Cardiac Mitochondrial Bioenergetics Impaired by Hyperglycaemia in a Model of Experimental Diabetes

By Labieniec-Watala Magdalena Siewiera Karolina Jozwiak Zofia

International Journal of Molecular Sciences, Vol. 12, Iss. 11, 2011-11 ,pp. : 8013-8026

MDPI

Access to resources Recommend Favorite

Combined lesions of direct and indirect basal ganglia pathways but not changes in dopamine levels explain learning deficits in patients with Huntington's disease

EUROPEAN JOURNAL OF NEUROSCIENCE, Vol. 41, Iss. 9, 2015-05 ,pp. : 1227-1244

John Wiley & Sons Inc

Access to resources Recommend Favorite

Executive function deficits and glutamatergic protein alterations in a progressive 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine mouse model of Parkinson's disease

JOURNAL OF NEUROSCIENCE RESEARCH, Vol. 93, Iss. 12, 2015-12 ,pp. : 1849-1864

John Wiley & Sons Inc

Access to resources Recommend Favorite